Eric A Button

from Raleigh, NC

Get Report

Also known as:

Eric Albert Button

Phone and address:: 1908 Eagle Creek Ct, Raleigh, NC 27606
336-341-0861

Connected to:

Eric Button Phones & Addresses

1908 Eagle Creek Ct, Raleigh, NC 27606 • 336-341-0861
Cary, NC
408 Chancery Park Ct, Kernersville, NC 27284
San Diego, CA
586 7 Lks, West End, NC 27376 • 910-673-3070
Advance, NC

Isbn (Books And Publications)

Eating Disorders: Personal Construct Therapy and Change

view source

Author
Eric Button

ISBN #
0471939056

Personal Construct Theory and Mental Health: Theory, Research and Practice

view source

Author
Eric Button

ISBN #
0914797158

Resumes

Chief Executive Officer And Founder

view source

Location:

Raleigh, NC

Industry:

Biotechnology

Work:

True Health Diagnostics Feb 2016 - May 2017
Senior Vice President of New Product Strategy
Neomark Ventures Feb 2016 - May 2017
President
Metabolon, Inc. Oct 2011 - Aug 2015
Senior Vice President Diagnostics
Glycomark 2004 - 2011
President and Founder
Amplistar 1999 - 2003
President and Founder

Education:

The University of British Columbia 1987
Master of Science, Masters, Genetics University of North Carolina at Greensboro

Skills:

Commercialization
Biotechnology
Medical Devices
Technology Transfer
Cross Functional Team Leadership
Glp
Licensing
Clinical Research
Fda
Validation
Product Development
R&D
Biomarkers
Strategy
Venture Capital
Clinical Trials
Drug Discovery
Global Strategy Development
Business Development
Marketing
Early Stage Startups
Turnaround Initiatives
Ipo
Regulatory Compliance
Fda Approval
Board Relations
Investor Relations
Emerging Technologies
Strategic Alliances
Kol Development
Advisory Boards
Board Governance
Evaluating Strategic Intent/Portfolio Viability/Patentability
Senior Executive Leadership
Creating Shareholder Value
Investor Liaison
Positioning Companies For Profitable Sale
Board of Directors
Addressing Unmet Diagnostic Needs
Driving Product Innovation
Patents
Regulatory Compliance/Fda Approval
Scientific/Clinical Advisory Boards
Group Presentations
Engaging Thought Leaders
Advising Executive Leaders
Joint Ventures
Strategic Partnerships
Board Development
Mergers and Acquisitions

Eric Button

view source

Eric Button

view source

Eric Dana Button

view source

Name / Title

Company / Classification

Phones & Addresses

Eric A. Button
President

PROTEOMIX, INCORPORATED

11526 Sorrento Vly Rd STE B, San Diego, CA 92121

Eric Button
Chief Executive Officer, President

Amplistar Inc
Research & Development

905 W Main St, Durham, NC 27701

Eric Button
Shareholder

ONCONIX INC
Mfg Diagnostic Substances

120 Wellesley Pl Ct, Lewisville, NC 27023
336-499-6814

Vehicle Records

Eric Button
view source
Address:

1908 Eagle Crk Ct, Raleigh, NC 27606
VIN:

1FAHP32N09W173560
Make:

FORD
Model:

FOCUS
Year:

2009

Us Patents

1,5-Anhydroglucitol (1,5-Ag) Assay And A1C/1,5-Ag Assay Combination For Measuring Blood Glucose Excursions In General And Postprandial Hyperglycemia In Diabetic Patients
view source
US Patent:

20080187943, Aug 7, 2008
Filed:

Apr 21, 2006
Appl. No.:

11/912171
Inventors:

John B. Buse - Chapel Hill NC, US
Kathleen Dungan - Durham NC, US
Steven D. Wittlin - Rochester NY, US
Eric A. Button - Kannapolis NC, US
Shuhei Kato - Tokyo, JP
Toshio Tanabe - Tokyo, JP
Assignee:

Nippon Kayaku Kabushiki Kisha - Tokyo
Toyota Tsusho America Inc. - New York NY
International Classification:

C12Q 1/54
C12M 1/00
US Classification:

435 14, 4352871
Abstract:

The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.

Identification Of Pre-Diabetes Using A Combination Of Mean Glucose And 1,5-Anhydroglucitol Markers
view source
US Patent:

20130260403, Oct 3, 2013
Filed:

Oct 19, 2011
Appl. No.:

13/880168
Inventors:

Eric A. Button - Cary NC, US
Robert Scott Foster - Charleston SC, US
International Classification:

C12Q 1/54
US Classification:

435 14
Abstract:

Described herein is a method for determining the disease state in a patient using combined mean glucose measurements and 1,5-anhydroglucitol to identify individuals at risk for developing diabetes. The ratio of mean glucose measurements to 1,5-anhydroglucitol correlates significantly better to maximal levels of postmeal glucose levels and related measurements, than mean glucose measurements or 1,5-anhydroglucitol correlate independently.